Related Experiment Video

Updated: May 20, 2025

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

1.3K

Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure

Ivan Sherstnev1,2,3, Aleksandra Judina1, Giovanni Battista Luciani2

  • 1Cardiac Section, National Heart and Lung Institute (NHLI), Faculty of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.

Cells
|March 26, 2025
PubMed

Insights

Phosphodiesterase 4 (PDE4) regulates heart cell signaling and function. Targeting specific PDE4 isoforms offers a promising strategy for treating heart failure and arrhythmias with reduced side effects.

Area of Science:

  • Cardiovascular Biology
  • Molecular Pharmacology
  • Cardiac Physiology

Background:

  • Phosphodiesterase 4 (PDE4) is crucial for regulating cyclic adenosine monophosphate (cAMP) signaling in cardiomyocytes.
  • PDE4 compartmentalization ensures spatial and temporal control of cAMP, impacting cardiac contractility, calcium handling, and hypertrophy.
  • Dysregulation of PDE4 contributes to cardiac pathophysiology, including heart failure and arrhythmias.

Purpose of the Study:

  • To review the roles of cardiac PDE4 isoforms (PDE4A, PDE4B, PDE4D) in cardiac physiology and pathophysiology.
  • To highlight the importance of PDE4 compartmentalization in human hearts, despite its lesser role in overall cAMP hydrolysis compared to rodents.
  • To discuss emerging therapeutic strategies targeting PDE4 for heart failure treatment.

Main Methods:

  • Review of existing literature integrating rodent and human studies on PDE4 function in the heart.
  • Analysis of PDE4 isoform-specific localization and their physiological and pathophysiological relevance.
  • Discussion of current and future therapeutic approaches, including isoform-specific inhibitors and gene therapies.

Main Results:

  • Cardiac PDE4 isoforms exhibit distinct subcellular localizations and functions.
  • PDE4's compartmentalized activity is critical for cardiac signaling, particularly under beta-adrenergic stimulation.
  • While PDE4's overall role in cAMP hydrolysis is less pronounced in human hearts than in rodents, its localized function remains vital.

Conclusions:

  • Selective targeting of PDE4 isoforms presents a promising therapeutic avenue for heart failure, aiming to restore cAMP compartmentation and prevent maladaptive cardiac remodeling.
  • Isoform-specific PDE4 modulators, gene therapies, and combination strategies offer potential for enhanced efficacy and reduced systemic toxicity.
  • Understanding the translational challenges and opportunities in PDE4 research is key to developing effective heart failure therapies.

Keywords:
A-kinase-anchoring proteinPhosphodiesterase 4Phosphodiesterase inhibitorarrhythmiacAMP compartmentationcAMP signallingcardiomyocyteβ-adrenergic signalling

More Related Videos

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes08:19

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes

Published on: June 22, 2020

6.0K
Isolation and Physiological Analysis of Mouse Cardiomyocytes11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

22.9K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
497
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
299
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
1.9K